Literature DB >> 11447342

Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice.

L Fattore1, G Cossu, M C Martellotta, S Deiana, W Fratta.   

Abstract

gamma-Hydroxybutyric acid (GHB) is a widely used recreational drug known to exert positive reinforcing effects in animals and humans. The GABA(B) receptor agonist baclofen has been proved to possess antimotivational effect and to inhibit alcohol, cocaine, heroin and nicotine intake. In the present study we evaluated the effect of baclofen on i.v. self-administration of GHB in drug-naive mice under a fixed-ratio (FR-1) schedule of reinforcement and nose-poking-like response as operandum. Results show that baclofen was able to completely prevent GHB seeking behaviour, decreasing the rate of responding to basal values, without showing any reinforcing properties when made contingent on nose-poking response. Our findings demonstrate that baclofen antagonises GHB i.v. self-administration, supporting an important role for the GABA(B) receptor in reward-related mechanisms underlying addictive behaviour.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447342     DOI: 10.1097/00001756-200107200-00039

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.

Authors:  Sonia Habibian; Keith Ahamad; Mark McLean; Maria Eugenia Socias
Journal:  J Addict Med       Date:  2019 Sep/Oct       Impact factor: 3.702

Review 2.  Behavioral analyses of GHB: receptor mechanisms.

Authors:  Lawrence P Carter; Wouter Koek; Charles P France
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

3.  Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.

Authors:  S Pons; L Fattore; G Cossu; S Tolu; E Porcu; J M McIntosh; J P Changeux; U Maskos; W Fratta
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

4.  Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.

Authors:  Rama M Kamal; Arnt Schellekens; Cornelis A J De Jong; Boukje A G Dijkstra
Journal:  BMC Psychiatry       Date:  2015-04-28       Impact factor: 3.630

5.  Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.

Authors:  Harmen Beurmanjer; Rama M Kamal; Cor A J de Jong; Boukje A G Dijkstra; Arnt F A Schellekens
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.